GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid medicines, today announced the acquisition of Nivagen Pharmaceuticals, Inc. ("Nivagen"),...
Hence then, the article about pai pharma acquires nivagen pharmaceuticals expanding domestic sterile injectable manufacturing and expanding ready to use rtu product offering in the hospital market was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market )
Also on site :
- 1979 Supertramp Hit, Ranked Among the ‘Greatest Classic Rock Songs’ Ever, Was Partially Recorded in a Bathroom
- Inside ‘Married at First Sight’ Season 20: How Peacock’s Changes Led to 1.8 Billion Minutes Viewed, That Wild Reunion and Why Lindsay Hubbard Said No to the Show
- Martha Stewart’s Retro 1960s-Inspired Bakeware Collection Brings Joy to Home Kitchens, Starting at $12